ABC | Volume 113, Nº2, August 2019

Original Article Coll et al Non-invasive cardiac output measurement Arq Bras Cardiol. 2019; 113(2):231-239 7. Rerych SK, Scholz PM, SabistonDC, Jr., Jones RH. Effects of exercise training on left ventricular function in normal subjects: a longitudinal study by radionuclide angiography. Am J Cardiol. 1980;45(2):244-52. 8. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol. 1981;47(1):33-9. 9. Wilson JR, Rayos G, Yeoh TK, Gothard P, Bak K. Dissociation between exertional symptoms and circulatory function in patients with heart failure. Circulation. 1995;92(1):47-53. 10. Ponikowski P, Voors AA, Anker SD, BuenoH, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891-975. 11. Myers J.Applicationsofcardiopulmonaryexercisetesting inthemanagement of cardiovascular and pulmonary disease. Int J Sports Med. 2005 Feb;26 (Suppl 1):S49-55. 12. Lang CC, Agostoni P, Mancini DM. Prognostic significance andmeasurement of exercise-derived hemodynamic variables in patients with heart failure. J Card Fail. 2007;13(8):672-9. 13. Becklake MR, Frank H, Dagenais GR, Ostiguy GL, Guzman CA. Influence of age and sex on exercise cardiac output. J Appl Physiol. 1965;20(5):938-47. 14. Wilson JR, Rayos G, Yeoh TK, Gothard P. Dissociation between peak exercise oxygen consumption and hemodynamic dysfunction in potential heart transplant candidates. J Am Coll Cardiol. 1995;26(2):429-35. 15. NicolettiI,CicoiraM,ZanollaL,FranceschiniL,BrighettiG,PilatiM,etal.Skeletal muscle abnormalities in chronic heart failure patients: relation to exercise capacity and therapeutic implications. Congest Heart Fail. 2003;9(3):148-54. 16. Lund-Johansen P. The dye dilution method for measurement of cardiac output. Eur Heart J. 1990 Dec;11(Suppl I):6-12. 17. WarburtonDE, HaykowskyMJ, QuinneyHA, HumenDP, Teo KK. Reliability and validity of measures of cardiac output during incremental to maximal aerobic exercise. Part II: Novel techniques and new advances. Sports Med. 1999;27(4):241-60. 18. Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003;348(1):5-14. 19. Harvey S, Stevens K, Harrison D, Young D, BramptonW, McCabe C, et al. An evaluation of the clinical and cost-effectiveness of pulmonary artery catheters inpatientmanagementinintensivecare:asystematicreviewandarandomised controlled trial. Health Technol Assess. 2006;10(29):iii-iv, ix-xi, 1-133. 20. Gordon N, Abbiss CR, Maiorana AJ, Marstron KJ, Peiffer JJ. Intrarater reliability and agreement of the physioflow bioimpedance cardiography device during rest, moderate and high-intensive exercise. Kinesiology. 2018;50(1 Suppl 1):140-9. 21. Maurer MM, Burkhoff D, MaybaumS, Franco V, Vittorio TJ, Williams P, et al. A multicenter study of noninvasive cardiac output by bioreactance during symptom-limited exercise. J Card Fail. 2009;15(8):689-99. 22. Keren H, Burkhoff D, Squara P. Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance. Am J Physiol Heart Circ Physiol. 2007;293(1):H583-9. 23. Jakovljevic DG, Moore S, Hallsworth K, Fattakhova G, Thoma C, Trenell MI. Comparison of cardiac output determined by bioimpedance and bioreactance methods at rest and during exercise. J Clin Monit Comput. 2012;26(2):63-8. 24. MarikPE,LevitovA,YoungA,AndrewsL.Theuseofbioreactanceandcarotid Doppler to determine volume responsiveness and blood flow redistribution following passive leg raising in hemodynamically unstable patients. Chest. 2013;143(2):364-70. 25. Elliott A, Hull JH, Nunan D, Jakovljevic DG, Brodie D, Ansley L. Application of bioreactance for cardiac output assessment during exercise in healthy individuals. Eur J Appl Physiol. 2010;109(5):945-51. 26. Jones TW, Houghton D, Cassidy S, MacGowan GA, Trenell MI, Jakovljevic DG. Bioreactance is a reliable method for estimating cardiac output at rest and during exercise. Br J Anaesth. 2015;115(3):386-91. 27. Tan LB. Evaluation of cardiac dysfunction, cardiac reserve and inotropic response. Postgrad Med J. 1991;67(Suppl 1):S10-20. 28. CotterG,WilliamsSG,VeredZ,TanLB.Roleofcardiacpower inheart failure. Curr Opin Cardiol. 2003;18(3):215-22. 29. Tan LB. Clinical and research implications of newconcepts in the assessment of cardiac pumping performance in heart failure. Cardiovasc Res. 1987;21(8):615-22. 30. Cooke GA, Marshall P, al-Timman JK,Wright DJ, Riley R, Hainsworth R, et al. Physiological cardiac reserve: development of a non-invasive method and first estimates in man. Heart. 1998;79(3):289-94. 31. Chomsky DB, Lang CC, Rayos GH, Shyr Y, Yeoh TK, Pierson RN 3rd, et al. Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates. Circulation. 1996;94(12):3176-83. 32. Wilson JR, Groves J, Rayos G. Circulatory status and response to cardiac rehabilitation in patients with heart failure. Circulation. 1996;94(7):1567-72. 33. Grodin JL, Mullens W, Dupont M, Wu Y, Taylor DO, Starling RC, et al. Prognostic role of cardiac power index in ambulatory patients with advanced heart failure. Eur J Heart Fail. 2015;17(7):689-96. 34. Williams SG, Cooke GA, Wright DJ, Parsons WJ, Riley RL, Marshall P, et al. Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J. 2001;22(16):1496-503. 35. LangCC,KarlinP,Haythe J,LimTK,ManciniDM.Peakcardiacpoweroutput, measured noninvasively, is a powerful predictor of outcome in chronic heart failure. Circ Heart Fail. 2009;2(1):33-8. 36. Bromley PD, Hodges LD, Brodie DA. Physiological range of peak cardiac power output in healthy adults. Clin Physiol Funct Imaging. 2006;26(4):240-6. 37. Schlader ZJ, Mundel T, Barnes MJ, Hodges LD. Peak cardiac power output in healthy, trained men. Clin Physiol Funct Imaging. 2010;30(6):480-4. 38. Marshall P, Al-Timman J, Riley R, Wright J, Williams S, Hainsworth R, et al. Randomized controlled trial of home-based exercise training to evaluate cardiac functional gains. Clin Sci (Lond). 2001;101(5):477-83. 39. Evangelista A, Gaudio C, De Castro S, Faletra F, Nesser HJ, Kuvin JT, et al. Three-dimensional echocardiography--state-of-the-art. Indian Heart J. 2008;60(3 Suppl C):C3-9. 40. Lang RM, BierigM, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber QuantificationWriting Group, developed in conjunctionwith the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-63. 41. Hoppe MW, Sperlich B, Baumgart C, Janssen M, Freiwald J. Reliability of selected parameters of cycling ergospirometry from the powercube-ergo respiratory gas analyser. Sportverletz Sportschaden. 2015;29(3):173-9. 42. Raval NY, Squara P, Cleman M, Yalamanchili K, Winklmaier M, Burkhoff D. Multicenter evaluation of noninvasive cardiac output measurement by bioreactance technique. J Clin Monit Comput. 2008;22(2):113-9. 43. Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J AmColl Cardiol. 2004;44(2):340-8. 238